Entrada Therapeutics Ownership & Insider Activity

Entrada Therapeutics (TRDA) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 3.1% of shares outstanding. Institutional investors hold 21.4%. Over the past 90 days, insiders made 12 sales worth $10.3M.

Shares Outstanding

38.937M

Shares Float

25.093M

Insider Shares Owned

1.207M

Insider % Owned

3.1%

Institutional Shares Held

8.317M

Institutional % Held

21.4%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$10.3M total

Net Activity

Net Selling

Net Value (90d)

-$10.3M

Entrada Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 4, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	259.837K	$7.33	$1.9M
Sep 4, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	259.837K	$7.33	$1.9M
Sep 1, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	86.482K	$7.14	$617K
Sep 1, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	86.482K	$7.14	$617K
Aug 27, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	86.914K	$7.08	$616K
Aug 27, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	86.914K	$7.08	$616K
Aug 24, 2026	MPM BioVentures LP, LUKE EVNIN, ANSBERT GADICKE, Todd Foley, MPM BioVentures B LP, MPM Asset Management Investors BV LLC, MPM BioVentures LLC, MPM BioVentures GP LLC, MPM BIOVENTURES B LP, MPM ASSET MANAGEMENT INVESTORS BV LLC	10% OWNER	SELL	62.714K	$7.36	$462K
Aug 24, 2026	MPM BIOVENTURES LP, MPM BioVentures LLC, MPM BioVentures GP LLC	10% OWNER	SELL	62.714K	$7.36	$462K
Aug 6, 2026	Kush Parmar	—	SELL	155.255K	$6.95	$1.1M
Aug 6, 2026	AM Ventures V LP, AM Partners V LLC, AM Opportunities I LP, AM Opportunities I GP LLC, SCOTT ROCKLAGE, Andrew Schwab	10% OWNER	SELL	62.811K	$6.88	$432K
Jul 30, 2026	AM Ventures V LP, AM Partners V LLC, AM Opportunities I LP, AM Opportunities I GP LLC, SCOTT ROCKLAGE, Andrew Schwab	10% OWNER	SELL	116.474K	$6.93	$807K
Jul 30, 2026	Kush Parmar	—	SELL	116.474K	$6.93	$807K
May 20, 2026	Bernhardt Zeiher	DIRECTOR	BUY	5.000K	$5.86	$29K
May 4, 2026	Natarajan Sethuraman	PRESIDENT, RESEARCH & DEVELOP.	SELL	25.907K	$15.39	$399K
May 4, 2026	Nathan Dowden	PRESIDENT & COO	SELL-OPTIONS	—	$8.54	$204K

More with Benzinga EdgeGet Access

Entrada Therapeutics Inc

Entrada Therapeutics Ownership & Insider Activity

Entrada Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch